A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC721 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC721 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d00160 and PBac{WH}CG12112f06346 insertion sites are 7D18;7F4.